Skip to main content
Premium Trial:

Request an Annual Quote

GlaxoSmithKline Purchases Ventana System for Automating DNA Microarray Analysis

NEW YORK, July 18 – Ventana Medical Systems said Wednesday that GlaxoSmithKline has chosen its Discovery in situ hybridization and immunohistochemistry system for use in DNA and protein expression experiments.

GlaxoSmithKline will install six to eight of Ventana’s systems in its European and North American research facilities, Ventana CEO Christopher Gleeson told GenomeWeb. The two companies will also collaborate to develop improvements in tissue gene expression profiling methods.

Ventana’s Discovery system automates the wet chemistry steps required for analyzing gene and protein expression experiments using DNA microarrays and tissue samples. The systems can analyze about 20 glass slides at a time using a carousel-type mechanism, and typically cost about $150,000, Gleeson said. Additional modules for added throughput cost about $120,000. 

Ventana has installed about 40 of the systems in US pharmaceutical and biotechnology company research labs since the company introduced the system in November 2000, Gleeson said.

Last week, Tucson, Ariz.-based Ventana signed an agreement with BD Biosciences Clontech Laboratories in which the companies will non-exclusively co-market each other’s microarray products.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.